Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Biology

Background:

• Lineage-determining transcription factors (TFs) control gene expression for cell identity.
• TF specificity is challenged by numerous potential binding sites in the genome.
• Chromatin remodelers are crucial for enhancer function and are often mutated in disease.

Purpose of the Study:

• To investigate the role of CHD4 in enhancer licensing and maintenance.
• To understand CHD4's function in breast cancer cells and cellular reprogramming.

Main Methods:

• Studied CHD4's role in chromatin accessibility modulation.
• Assessed TF redistribution upon CHD4 depletion.
• Examined CHD4's necessity for preventing aberrant chromatin opening during reprogramming.

Main Results:

• CHD4 depletion in breast cancer cells caused TFs to bind unintended sites.
• CHD4 activity was essential to prevent inappropriate chromatin opening during GATA3-induced reprogramming.
• CHD4 functions by positioning nucleosomes to block TF-DNA interactions at specific motifs.

Conclusions:

• CHD4 acts as a chromatin proofreading enzyme.
• It prevents spurious TF binding and inappropriate gene expression.
• This mechanism is critical for maintaining cell specificity and preventing cancer-associated gene dysregulation.